TY - JOUR
T1 - Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome
T2 - A randomized trial
AU - He, Mingqian
AU - Wang, Jingya
AU - Liang, Qian
AU - Li, Meng
AU - Guo, Hui
AU - Wang, Yue
AU - Deji, Cuomu
AU - Sui, Jing
AU - Wang, Ya wen
AU - Liu, Yufeng
AU - Zheng, Yixuan
AU - Qian, Buyue
AU - Chen, Huaixi
AU - Ma, Mao
AU - Su, Shi
AU - Geng, Hui
AU - Zhou, Wen xu
AU - Guo, Xiaoxiao
AU - Zhu, Wen zhi
AU - Zhang, Meng
AU - Chen, Ziyi
AU - Rensen, Patrick C.N.
AU - Hui, Chi chung
AU - Wang, Yanan
AU - Shi, Bingyin
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2022/10/18
Y1 - 2022/10/18
N2 - Overconsumption of carbohydrate-rich food combined with adverse eating patterns contributes to the increasing incidence of metabolic syndrome (MetS) in China. Therefore, we conducted a randomized trial to determine the effects of a low-carbohydrate diet (LCD), an 8-h time-restricted eating (TRE) schedule, and their combination on body weight and abdominal fat area (i.e., primary outcomes) and cardiometabolic outcomes in participants with MetS. Compared with baseline, all 3-month treatments significantly reduce body weight and subcutaneous fat area, but only TRE and combination treatment reduce visceral fat area (VFA), fasting blood glucose, uric acid (UA), and dyslipidemia. Furthermore, compared with changes of LCD, TRE and combination treatment further decrease body weight and VFA, while only combination treatment yields more benefits on glycemic control, UA, and dyslipidemia. In conclusion, without change of physical activity, an 8-h TRE with or without LCD can serve as an effective treatment for MetS (ClinicalTrials.gov: NCT04475822).
AB - Overconsumption of carbohydrate-rich food combined with adverse eating patterns contributes to the increasing incidence of metabolic syndrome (MetS) in China. Therefore, we conducted a randomized trial to determine the effects of a low-carbohydrate diet (LCD), an 8-h time-restricted eating (TRE) schedule, and their combination on body weight and abdominal fat area (i.e., primary outcomes) and cardiometabolic outcomes in participants with MetS. Compared with baseline, all 3-month treatments significantly reduce body weight and subcutaneous fat area, but only TRE and combination treatment reduce visceral fat area (VFA), fasting blood glucose, uric acid (UA), and dyslipidemia. Furthermore, compared with changes of LCD, TRE and combination treatment further decrease body weight and VFA, while only combination treatment yields more benefits on glycemic control, UA, and dyslipidemia. In conclusion, without change of physical activity, an 8-h TRE with or without LCD can serve as an effective treatment for MetS (ClinicalTrials.gov: NCT04475822).
KW - abdominal obesity
KW - low-carbohydrate diet
KW - metabolic syndrome
KW - time-restricted eating
KW - visceral fat area
UR - https://www.scopus.com/pages/publications/85140056630
U2 - 10.1016/j.xcrm.2022.100777
DO - 10.1016/j.xcrm.2022.100777
M3 - 文章
C2 - 36220069
AN - SCOPUS:85140056630
SN - 2666-3791
VL - 3
JO - Cell Reports Medicine
JF - Cell Reports Medicine
IS - 10
M1 - 100777
ER -